Details

Last Funding Type

Series Unknown

Last Funding Money Raised

£1.10M

Industries

Biotechnology,Genetics,Health Care,Nanotechnology

Founded date

Aug 1, 2007

Number Of Employee

11 - 50

Operating Status

Active

nanoTherics gene transfection studies have shown a significant performance enhancement over the best non-viral techniques currently on the market, demonstrating high levels of transfection whilst, importantly, maintaining the viability of the transfected cells. These two key attributes afford a significant competitive advantage over currently available systems.

nanoTherics’s mission is to position its novel gene transfection technology as the new “gold standard” for transfection, underpinning the research and development of current and future gene therapy programmes.